血液型検査、分類及び感染症NATスクリーニングの日本市場2019-2023

【英語タイトル】Japan Blood Typing, Grouping and Infectious Disease NAT Screening Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Opportunities for Suppliers

Venture Planning Groupが出版した調査資料(VPG906175)・商品コード:VPG906175
・発行会社(調査会社):Venture Planning Group
・発行日:2019年5月
・ページ数:430
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:日本
・産業分野:医療
◆販売価格オプション(消費税別)
Local PDFUSD6,100 ⇒換算¥652,700見積依頼/購入/質問フォーム
Global PDFUSD9,500 ⇒換算¥1,016,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Complete report $7,700.  DataPack (test volumes, sales forecasts, supplier shares) $4,950.

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR,
Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream,
Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS,
Mini-Sequencing

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG,  C3),
Crossmatching (Immediate Spin, Full Crossmatch),
Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,  
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT

Sales and Market Share Analysis

Sales and market share estimates for leading
suppliers of blood banking products by individual product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
  analysis, including review of the market
  dynamics, trends, structure, size, growth,
  and key suppliers.

- Test volume and sales forecasts for over 40 blood typing,
  grouping and infectious disease screening tests,
  including NAT, by market segment:

     – Blood Centers
     – Hospitals
     – Commercial/Private Laboratories

Current and Emerging Products

- Analysis of current and emerging blood typing,
  grouping and infectious disease screening tests.

- Review of automated and semi-automated
  analyzers.

Technology Review

- Assessment of current and emerging
  Technologies, and their potential applications
  for the blood banking market.

- Comprehensive lists of companies developing
  or marketing new Technologies and products, by test.

Strategic Recommendations

- New product development
  opportunities with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 430 pages and 36 tables

【レポートの目次】

http://www.LeadingMarketResearch.com/pdffiles/LOT2015JapanTransfusionDiagnosticsMarket.pdf

http://www.vpgcorp.com/webfiles/BLOOD%20BANKING/BBCompanyProfiled.pdf

【掲載企業】

Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher


★調査レポート[血液型検査、分類及び感染症NATスクリーニングの日本市場2019-2023] (コード:VPG906175)販売に関する免責事項を必ずご確認ください。
★調査レポート[血液型検査、分類及び感染症NATスクリーニングの日本市場2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆